BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22906929)

  • 1. Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma.
    Kelleher FC; Cain JE; Healy JM; Watkins DN; Thomas DM
    Pharmacol Ther; 2012 Nov; 136(2):153-68. PubMed ID: 22906929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitors of the Hedgehog signalling pathway: hope for the treatment of basal cell carcinoma].
    Vidal V
    Med Sci (Paris); 2010 Mar; 26(3):231-3. PubMed ID: 20346268
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition.
    Metcalfe C; Alicke B; Crow A; Lamoureux M; Dijkgraaf GJ; Peale F; Gould SE; de Sauvage FJ
    Cancer Res; 2013 Dec; 73(23):7034-42. PubMed ID: 24154871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
    Cirrone F; Harris CS
    Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GLI2 in the growth of human osteosarcoma.
    Nagao H; Ijiri K; Hirotsu M; Ishidou Y; Yamamoto T; Nagano S; Takizawa T; Nakashima K; Komiya S; Setoguchi T
    J Pathol; 2011 Jun; 224(2):169-79. PubMed ID: 21506130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments and signaling pathway inhibitors.
    Tang JY; Marghoob AA
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S14-8. PubMed ID: 22177102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].
    Watson S; Serrate C; Vignot S
    Bull Cancer; 2010 Dec; 97(12):1477-83. PubMed ID: 21220225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vismodegib: a promising drug in the treatment of basal cell carcinomas.
    Dirix L; Rutten A
    Future Oncol; 2012 Aug; 8(8):915-28. PubMed ID: 22894666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma.
    Lindemann RK
    Cancer Res; 2008 Feb; 68(4):961-4. PubMed ID: 18281468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTHrP regulates growth plate chondrocyte differentiation and proliferation in a Gli3 dependent manner utilizing hedgehog ligand dependent and independent mechanisms.
    Mau E; Whetstone H; Yu C; Hopyan S; Wunder JS; Alman BA
    Dev Biol; 2007 May; 305(1):28-39. PubMed ID: 17328886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
    Walls B
    Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling.
    Hameetman L; Rozeman LB; Lombaerts M; Oosting J; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    J Pathol; 2006 Aug; 209(4):501-11. PubMed ID: 16755518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.
    Hallahan AR; Pritchard JI; Hansen S; Benson M; Stoeck J; Hatton BA; Russell TL; Ellenbogen RG; Bernstein ID; Beachy PA; Olson JM
    Cancer Res; 2004 Nov; 64(21):7794-800. PubMed ID: 15520185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDC-0449-a potent inhibitor of the hedgehog pathway.
    Robarge KD; Brunton SA; Castanedo GM; Cui Y; Dina MS; Goldsmith R; Gould SE; Guichert O; Gunzner JL; Halladay J; Jia W; Khojasteh C; Koehler MF; Kotkow K; La H; Lalonde RL; Lau K; Lee L; Marshall D; Marsters JC; Murray LJ; Qian C; Rubin LL; Salphati L; Stanley MS; Stibbard JH; Sutherlin DP; Ubhayaker S; Wang S; Wong S; Xie M
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5576-81. PubMed ID: 19716296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vismodegib in metastasized basal cell carcinoma].
    Reinders MG; Dirix L; Mosterd K; van Doorn R
    Ned Tijdschr Geneeskd; 2013; 157(12):A6011. PubMed ID: 23515044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma.
    Amin SH; Tibes R; Kim JE; Hybarger CP
    Laryngoscope; 2010 Dec; 120(12):2456-9. PubMed ID: 20927781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
    Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
    J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis.
    Chen X; Horiuchi A; Kikuchi N; Osada R; Yoshida J; Shiozawa T; Konishi I
    Cancer Sci; 2007 Jan; 98(1):68-76. PubMed ID: 17083567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
    Sobanko JF; Okman J; Miller C
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.